Primary Hepatosplenic B-cell Lymphoma: Iinitial Diagnosis and Assessment of Therapeutic Response with F-18 FDG PET/CT / 핵의학분자영상
Nuclear Medicine and Molecular Imaging
;
: 333-336, 2008.
Article
in English
| WPRIM
| ID: wpr-227105
ABSTRACT
A 52-year-old woman with a history of general weakness, fatigue, weight loss, elevated serum levels of liver transaminase enzyme for three months underwent an F-18 FDG PET/CT scan to evaluate a cause of the hepatosplenomegaly found on abdominal ultrasonography. Initial PET/CT revealed markedly enlarged liver and spleen with intense FDG uptake. Otherwise, there were no areas of abnormal FDG uptake in whole body image. Histological evaluation by a hepatic needle biopsy demonstrated diffuse large B cell type lymphoma and final diagnosis for this patient was hepatosplenic B-cell lymphoma. She received five cycles of CHOP chemotherapy, and second PET/CT scan was followed after then. Follow-up PET-CT revealed normal sized liver with disappearance of abnormal FDG uptake. Hepatosplenic B-cell lymphoma is relatively rare and mostly presents as single or multiple nodules.1,2 Diffuse type hepatosplenic lymphoma is extremely rare and poorly recognized entity.3 The diagnosis is very difficult and complicated by the presence of misleading symptoms.4 In this rare hepatosplenic B-cell lymphoma case, F-18 FDG PET/CT scan provided a initial diagnostic clue of hepatosplenic lymphoma and an accurate chemotherapy response.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Spleen
/
Biopsy, Needle
/
Body Image
/
B-Lymphocytes
/
Weight Loss
/
Follow-Up Studies
/
Lymphoma, B-Cell
/
Fatigue
/
Hepatomegaly
/
Liver
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Nuclear Medicine and Molecular Imaging
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS